clinical trial · NCT07538570
Evaluation of Pain Treatment After Total Knee Arthroplasty
Vertex Pharmaceuticals Incorporated·phase4·recruiting·n = 60
PainSuzetriginePlacebo
brief summary
The purpose of the study is to characterize opioid use after total knee arthroplasty (TKA).
started
Apr 24, 2026
primary completion
Jan 30, 2027
completion
Jan 30, 2027
last updated
May 13, 2026
official title
A Phase 4, Double-blind, Sequential Cohort Study of Pain Treatment and Recovery After Total Knee Arthroplasty
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol